181 related articles for article (PubMed ID: 37992141)
1. Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review.
Monteiro MF; Lemos JG; Pontes FS; Silva AC; Silva MH; Silva NF; Souza LL; Uchôa DC; Pontes HA
Med Oral Patol Oral Cir Bucal; 2024 Jan; 29(1):e135-e144. PubMed ID: 37992141
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Szeto CH; Shek TW; Lie AK; Au WY; Yuen AP; Kwong YL
Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
[TBL] [Abstract][Full Text] [Related]
3. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation.
Montebugnoli L; Gissi DB; Marchetti C; Foschini MP
Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622
[TBL] [Abstract][Full Text] [Related]
4. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
Woelfinger P; Hauptrock B; Kriege O; Wagner W; Heider J; Schwarting A; Birklein F; Theobald M; Wagner-Drouet EM
Transplant Proc; 2021 May; 53(4):1365-1368. PubMed ID: 33478746
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
9. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
11. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.
Mawardi H; Elad S; Correa ME; Stevenson K; Woo SB; Almazrooa S; Haddad R; Antin JH; Soiffer R; Treister N
Bone Marrow Transplant; 2011 Jun; 46(6):884-91. PubMed ID: 21460866
[TBL] [Abstract][Full Text] [Related]
12. Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation.
Tamma R; Limongelli L; Maiorano E; Pastore D; Cascardi E; Tempesta A; Carluccio P; Mastropasqua MG; Capodiferro S; Covelli C; Pentenero M; Annese T; Favia G; Specchia G; Ribatti D
Ann Hematol; 2019 Apr; 98(4):979-986. PubMed ID: 30519712
[TBL] [Abstract][Full Text] [Related]
13. Multiple and Recurrent Squamous Cell Carcinoma of the Oral Cavity After Graft-Versus-Host Disease.
Weng X; Xing Y; Cheng B
J Oral Maxillofac Surg; 2017 Sep; 75(9):1899-1905. PubMed ID: 28322198
[TBL] [Abstract][Full Text] [Related]
14. Severe gingival recession and early loss of teeth in a child with chronic graft versus host disease: a case report.
da Fonseca MA; Murdoch-Kinch CA
Spec Care Dentist; 2007; 27(2):59-63. PubMed ID: 17539221
[TBL] [Abstract][Full Text] [Related]
15. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
16. Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years.
Kruse AL; Grätz KW
Head Neck Oncol; 2009 Jul; 1():29. PubMed ID: 19624855
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: A systematic review and a comprehensive meta-analysis.
González-Moles MÁ; Warnakulasuriya S; González-Ruiz I; González-Ruiz L; Ayén Á; Lenouvel D; Ruiz-Ávila I; Ramos-García P
Oral Oncol; 2020 Jul; 106():104688. PubMed ID: 32305649
[TBL] [Abstract][Full Text] [Related]
19. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
20. Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort.
Gomes N; Huynh A; Borel C; Guenounou S; Recher C; Barres B; Vigarios E; Sibaud V
Oral Oncol; 2021 Mar; 114():105082. PubMed ID: 33187825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
